Join us for part two of our virtual showcase of Koch Institute cancer researchers who have pivoted existing research to address biomedical challenges related to the COVID-19 pandemic. Four MIT faculty members will share their work developing new treatment strategies and interventions for the disease. After each presentation, a brief moderated Q&A session will allow participants to learn more about the science and understand how the Koch Institute’s flexible, collaborative research models accelerate innovation in the face of rapidly evolving understanding.
Featuring
Michael Yaffe, MD, PhD
David H. Koch Professor of Science
Intensive Care Physician, Beth Israel Deaconess Medical Center
Overcoming respiratory distress
Angela Koehler
Samuel A. Goldblith Career Development Professor in Applied Biology
Novel therapeutic candidates
Sangeeta Bhatia, MD, PhD
John J. and Dorothy Wilson Professor of Health Sciences and Technology and of Electrical Engineering and Computer Science
Nanomedicine for monitoring, prevention and therapy
Robert Langer, PhD
David H. Koch Institute Professor
Drug and vaccine delivery
Moderated by
Salil Garg, MD, PhD
Charles W. (1955) and Jennifer C. Johnson Clinical Investigator
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
